Intensity Therapeutics, Inc. (INTS) Investor Relations Documents

Intensity Therapeutics, Inc. (INTS) investor relations documents from the company's IR site: 36 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-11Press releaseIntensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-04Press releaseIntensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026
2026-07-15Press releaseIntensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Pha
2026-07-01Press releaseIntensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Op
2026-05-30Press releasehttps://www.prnewswire.com/news-releases/intensity-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update-302766229.html
2026-05-14Press releaseIntensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award
2026-05-07Press releaseIntensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
2026-05-07Press releasePDF
2026-04-15Press releaseIntensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation
2026-03-27Press releaseEarnings Release
2026-03-27Press releaseIntensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update
2026-03-27Press releasePDF
2026-03-24Press releaseIntensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US
2026-03-12Press releaseIntensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study
2025-11-06Press releasePDF
2025-08-07Press releasePDF
2025-05-13Press releasePDF
2025-03-13Press releasePDF
2025-03-13Press releaseIntensity Therapeutics Reports 2024 Year End Financial Results and Provides Corporate Update
2024-11-13Press releaseEarnings Release
2024-11-13Press releasePDF
2024-11-13Press releaseIntensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
2024-08-08Press releaseEarnings Release
2024-08-08Press releasePDF
2024-08-08Press releaseIntensity Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
2024-05-09Press releaseEarnings Release
2024-05-09Press releasePDF
2024-05-09Press releaseIntensity Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
2024-03-14Press releaseIntensity Therapeutics to Participate in the 36th Annual Roth Conference March 17 to 19, 2024
2024-03-14Press releasePDF
2024-03-14Press releaseIntensity Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
2023-11-13Press releasePDF
2023-11-13Press releaseIntensity Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
2023-08-14Press releasePDF
2023-08-14Press releaseIntensity Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
2023-08-07Press releaseIntensity Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2023, and Provide Corporate U

INTS overview · INTS earnings · INTS financials · INTS KPIs · INTS ownership · INTS peers · INTS filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.